These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9783838)

  • 21. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
    Donovan DM; Miner LL; Perry MP; Revay RS; Sharpe LG; Przedborski S; Kostic V; Philpot RM; Kirstein CL; Rothman RB; Schindler CW; Uhl GR
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):37-49. PubMed ID: 10581396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
    Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders.
    Scearce-Levie K; Chen JP; Gardner E; Hen R
    Ann N Y Acad Sci; 1999 Apr; 868():701-15. PubMed ID: 10414358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
    Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addiction becomes a brain disease.
    Wise RA
    Neuron; 2000 Apr; 26(1):27-33. PubMed ID: 10798389
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.
    Picciotto MR; Zoli M; Rimondini R; Léna C; Marubio LM; Pich EM; Fuxe K; Changeux JP
    Nature; 1998 Jan; 391(6663):173-7. PubMed ID: 9428762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression.
    Lanfumey L; Mannoury La Cour C; Froger N; Hamon M
    Neurochem Res; 2000 Oct; 25(9-10):1199-206. PubMed ID: 11059794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of genetics to the concept of risk status for alcohol dependence].
    Gorwood P
    J Soc Biol; 2000; 194(1):43-9. PubMed ID: 11107549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of cocaine-induced place conditioning in serotonin 1B receptor knock-out mice.
    Belzung C; Scearce-Levie K; Barreau S; Hen R
    Pharmacol Biochem Behav; 2000 May; 66(1):221-5. PubMed ID: 10837864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs.
    Sora I; Li B; Igari M; Hall FS; Ikeda K
    Ann N Y Acad Sci; 2010 Feb; 1187():218-46. PubMed ID: 20201856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurobiology of addiction to drugs of abuse].
    Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
    Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter.
    Gonon F; Burie JB; Jaber M; Benoit-Marand M; Dumartin B; Bloch B
    Prog Brain Res; 2000; 125():291-302. PubMed ID: 11098665
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
    Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug abuse and mental illness: progress in understanding comorbidity.
    Volkow ND
    Am J Psychiatry; 2001 Aug; 158(8):1181-3. PubMed ID: 11481146
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
    Ase AR; Reader TA; Hen R; Descarries L
    J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter.
    Rioux A; Fabre V; Lesch KP; Moessner R; Murphy DL; Lanfumey L; Hamon M; Martres MP
    Neurosci Lett; 1999 Mar; 262(2):113-6. PubMed ID: 10203244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development.
    Le Moine C; Fauchey V; Jaber M
    Neuroscience; 2002; 112(1):131-9. PubMed ID: 12044478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.